Ceva recently received European marketing approval for Tulaven, a branded generic for Tulathromycin, an antibacterial product for the treatment of respiratory disease in beef cattle (BRD), Swine (SRD) and Sheep and for Metaphylaxia.
From Tulathromycin and ventus; strong/confident sounding, provides clear link to generic, suggests enhanced respiratory disease treatment, long-lasting/consistency and trust/support, easily pronounced and recalled
Tulaven will become an important and integral part of Ceva’s comprehensive AI product portfolio.